Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
-
Vitamin a derivative combined with immunotherapy shows promise in early lung cancer trial
Disease control OngoingThis early-phase trial is testing a combination of all-trans retinoic acid (ATRA), a substance made from vitamin A, and the immunotherapy drug atezolizumab in people with advanced non-small cell lung cancer that has spread or come back. The main goal is to find the safest dose an…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
New drug combo shows promise for rare thymic cancer
Disease control OngoingThis study tested a combination of two drugs, pembrolizumab and sunitinib, in 9 people with advanced thymic cancer that had spread or could not be removed and had stopped responding to standard chemotherapy. The goal was to see if the combination could shrink tumors or stop them …
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New combo tackles tough cancers: hope for patients out of options
Disease control OngoingThis study tests a combination of two drugs—nivolumab (an immunotherapy that helps the immune system fight cancer) and temozolomide (a chemotherapy drug)—in people with advanced small-cell lung cancer or neuroendocrine tumors that have come back or stopped responding to standard …
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC